239 related articles for article (PubMed ID: 3167858)
1. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture.
Hill SM; Blask DE
Cancer Res; 1988 Nov; 48(21):6121-6. PubMed ID: 3167858
[TBL] [Abstract][Full Text] [Related]
2. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
[TBL] [Abstract][Full Text] [Related]
3. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture.
Blask DE; Hill SM
J Neural Transm Suppl; 1986; 21():433-49. PubMed ID: 3462341
[TBL] [Abstract][Full Text] [Related]
4. Melatonin and mammary pathological growth.
Cos S; Sánchez-Barceló EJ
Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
[TBL] [Abstract][Full Text] [Related]
5. Transient inhibition of synergistically insulin-like growth factor-1- and bisphenol A-induced poliferation of estrogen receptor alpha (ERalpha)-positive human breast cancer MCF-7 cells by melatonin.
Ishido M
Environ Sci; 2004; 11(3):163-70. PubMed ID: 15750583
[TBL] [Abstract][Full Text] [Related]
6. Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7.
Czeczuga-Semeniuk E; Wołczyński S; Anchim T; Dziecioł J; Dabrowska M; Pietruczuk M
Pol J Pathol; 2002; 53(2):59-65. PubMed ID: 12140868
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
[TBL] [Abstract][Full Text] [Related]
8. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.
Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V
Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572
[TBL] [Abstract][Full Text] [Related]
9. Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway.
Blask DE; Wilson ST; Zalatan F
Cancer Res; 1997 May; 57(10):1909-14. PubMed ID: 9157984
[TBL] [Abstract][Full Text] [Related]
10. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
[TBL] [Abstract][Full Text] [Related]
11. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
[TBL] [Abstract][Full Text] [Related]
12. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.
Blask DE; Dauchy RT; Brainard GC; Hanifin JP
Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410
[TBL] [Abstract][Full Text] [Related]
13. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
[TBL] [Abstract][Full Text] [Related]
14. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
Mueck AO; Seeger H; Wallwiener D
Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
[TBL] [Abstract][Full Text] [Related]
15. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
16. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
[TBL] [Abstract][Full Text] [Related]
17. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the polyamine pathway in antiestrogen-induced growth inhibition of human breast cancer.
Cohen FJ; Manni A; Glikman P; Bartholomew M; Demers L
Cancer Res; 1988 Dec; 48(23):6819-25. PubMed ID: 3180091
[TBL] [Abstract][Full Text] [Related]
19. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events.
Blask DE; Sauer LA; Dauchy RT; Holowachuk EW; Ruhoff MS; Kopff HS
Cancer Res; 1999 Sep; 59(18):4693-701. PubMed ID: 10493527
[TBL] [Abstract][Full Text] [Related]
20. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]